27
Participants
Start Date
October 31, 2011
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
DT01
"DT01 starting dose will be 16 mg and it is planned to be increased to 32, 48 mg and 64 mg, or higher.~DT01 will be administered 3 times a week (e.g., Mondays, Wednesdays and Fridays) over 2 weeks (6 administrations of DT01 in total) at least 3 hours prior to the radiotherapy sessions."
Hôpital de la Timone, Marseille
Hôpital Saint-André, Bordeaux
Hôpital hôtel-Dieu, Nantes
Centre Oscar Lambret, Lille
Centre Hospitalier Lyon Sud, Pierre-Bénite
Groupe Hospitalier Cochin - Hôtel Dieu-Broca, Paris
Institut Curie, Paris
Hôpital Saint-Louis, Paris
APHP Hôpital Bichat - Claude Bernard, Paris
Hôpital Charles Nicolle, Rouen
Hôpital Ambroise Paré, Boulogne-Billancourt
CHU de Nice - Archet 2, Nice
Lead Sponsor
DNA Therapeutics
INDUSTRY